Weekly Recap | AKESO +12.57%, ivonescimab hits survival endpointWeekly Review·Sep 5 at 05:56 AM09926-1.53%
Weekly Recap | WUXI APPTEC +0.95%, consensus target above spotWeekly Review·Sep 5 at 05:06 AM02359-1.14%
Weekly Recap | INNOVENT BIO -1.35%, most brokers rate it buyWeekly Review·Sep 5 at 04:56 AM01801-3.92%
Weekly Recap | AKESO +7.92%, ivonescimab Phase III hits endpointWeekly Review·Aug 29 at 05:06 AM09926-1.53%
Weekly Recap | BEONE MEDICINES +1.36%, FDA nod and 385% interim profit jumpWeekly Review·Aug 29 at 04:52 AM06160-0.77%
Weekly Recap | WUXI APPTEC -0.3%, closing in on record highsWeekly Review·Aug 29 at 04:31 AM02359-1.14%
Weekly Recap | INNOVENT BIO +8.04%, earnings beat estimatesWeekly Review·Aug 29 at 04:21 AM01801-3.92%
Weekly Recap | INNOVENT BIO +7.39%, closing in on record highsWeekly Review·Aug 22 at 06:51 AM01801-3.92%
Weekly Recap | AKESO -0.28%, new drug progress fuels swingsWeekly Review·Aug 22 at 04:29 AM09926-1.53%
Weekly Recap | BEONE MEDICINES +6.54%, most brokers rate it buyWeekly Review·Aug 22 at 04:19 AM06160-0.77%
Weekly Recap | WUXI APPTEC +1.18%, closing in on record highsWeekly Review·Aug 22 at 04:08 AM02359-1.14%
